| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3188834 | Annales de Dermatologie et de Vénéréologie | 2011 | 8 Pages |
Abstract
Data from the literature did not allow identifying the best therapeutic regimen, mainly because of the lack of prospective comparative studies. Dapsone remains the first line treatment in MMP. Immunosuppressive or immunomodulating drugs should be discussed patient by patient.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
C. Bédane, V. Doffoel Hantz,